Welcome to our dedicated page for BXP news (Ticker: BXP), a resource for investors and traders seeking the latest updates and insights on BXP stock.
BXP, Inc. operates as a fully integrated real estate investment trust that develops, owns, and manages premier workplaces in Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. Company news commonly covers leasing volume, occupancy, client expansions, development and redevelopment projects, strategic asset sales, acquisitions, and portfolio repositioning across urban gateway markets.
Updates also include quarterly operating results, FFO and EPS guidance, dividend declarations, distribution tax treatment, capital allocation priorities, and conference presentations addressing the office operating environment, investment activity, and balance sheet strategy.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
BXP (NYSE: BXP) announced the development of two fully pre-leased life sciences projects in Cambridge, Massachusetts, totaling over 800,000 square feet. The first quarter of 2023 saw a revenue increase of 6.5% to $803.2 million compared to $754.3 million in Q1 2022. However, net income dropped significantly from $143.0 million to $77.9 million, primarily due to higher depreciation and interest expenses. Funds from Operations (FFO) also decreased from $286.1 million to $272.0 million. Despite these setbacks, BXP exceeded its FFO guidance but fell short on EPS by $0.03. The company maintains a strong portfolio with about 660,000 square feet of leases executed. Guidance for Q2 2023 EPS is set at $0.59 - $0.61, with FFO projected between $1.79 - $1.81 per share.